000 03874nam a22003255i 4500
999 _c403038
_d403038
001 403038
003 ES-MaUEC
005 20240711101213.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 240229s2023 si | o |||| 0|eng d
020 _a9789819970285
024 7 _a10.1007/978-981-99-7028-5
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC881.5
_b2023 EB
245 0 0 _aGenetic Testing in Reproductive Medicine
_cedited by Rajender Singh
250 _a1st ed. 2023
264 1 _aSingapore
_bSpringer International Publishing
_c2023
300 _a1 recurso en línea
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aChapter 1. Genetic testing in disorders of sexual development -- Chapter 2. Y-chromosome deletion testing in infertility -- Chapter 3. Genetic testing in male infertility -- Chapter 4. Sperm DNA fragmentation testing in infertility -- Chapter 5. Microbiome testing in male infertility -- Chapter 6. Genetic testing in polycystic ovary syndrome -- Chapter 7. Genetic testing in premature ovarian failure -- Chapter 8. Microbiome testing in female infertility -- Chapter 9. Preimplantation Genetic Testing -- Chapter 10. Mitochondrial DNA Testing in Assisted Reproduction -- Chapter 11. Genetic testing for endometrial receptivity -- Chapter 12. Prenatal Genetic Testing -- Chapter 13. Genetic testing in recurrent pregnancy loss -- Chapter 14. Genetic testing in pregnancy to assess the risk of pre-term birth -- Chapter 15. Reproductive Carrier Screening -- Chapter 16. Genetic testing in endometrial cancer -- Chapter 17. Genetic Testing in Cervical Cancer -- Chapter 18. Ethical solicitude in reproductive carrier screening -- Chapter 19. Genetic Counselling in Reproductive Medicine -- Chapter 20. Challenges in Reproductive Carrier Screening.
520 _aThis textbook illustrates the importance and significance of molecular genetic testing in reproductive disorders. The present book covers the genetic testing in various reproductive system anomalies, including disorders of sexual development, male infertility (Y deletions, autosomal mutations, sperm DNA fragmentation), female infertility (PCOS and POF), mitochondrial DNA testing for oocyte quality, recurrent pregnancy loss, pre-term birth, endometrial receptivity, prenatal genetic screening, reproductive carrier screening, preimplantation genetic screening, endometrial cancer, cervical cancer and other related reproductive health disorders. Microbiome testing and its contribution to genetic testing in reproductive medicine are also discussed. Genetic testing in some of these has already come into practice, genetic testing for others is established but not clinically practiced, and genetic testing for others is yet in infancy as there is only limited data available. For the disorders where sufficient genetic data to undertake genetic testing is not available, we have tried to put together the evidence for proposing such tests in the near future. Apart from this, the book also covers ethical, moral and technical challenges in genetic testing in reproductive medicine. The book aims to set up a standard with regard to genetic testing in the reproductive medicine field, encourage further data generation, and provide food for thought in the areas of lacunae. The book serves graduate students, researchers, clinicians, professors, and patients in the field of reproductive medicine.
988 _aSpringer_Medicine_2023
650 7 _2embne
_9677625
_aAnomalías cromosómicas
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-99-7028-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b07/2024
_dz
_eu
_zSI